Latest News
China's Sinovac planning on COVID-19 vaccine distribution in South America
24 September 2020 - The chairman of Sinovac Biotech (Sinovac)(NasdaqGS:SVA), a vaccine focused biopharmaceutical company in China, Yin Weidong, has said the company hopes to supply its experimental COVID-19 vaccine to more South American countries by...
BioNTech states no role for its COVID-19 vaccine in UK challenge trial
24 September 2020 - German biotechnology company BioNTech SE (Nasdaq:BNTX), the development partner with Pfizer for a COVID-19 vaccine, on 24 September 2020 joined other leading COVID-19 vaccine developers in ruling out participation in Britain'...
Veeva, Bioforum Partner with RedHill Biopharma to Maximize Value of Opaganib Phase 2/3 COVID-19 Clinical Data
24 September 2020 - - US-based cloud computing company Veeva Systems (NYSE: VEEV) and Israel-based clinical research organisation Bioforum have forged collaboration with Israel-based specialty biopharmaceutical RedHill Biopharma L...
Sinovac's Coronavac, SARS-CoV-2 Vaccine, Inactivated, Announces Approval for Phase I/II Clinical Trial in Adolescents and Children
24 September 2020 - - An inactivated COVID-19 vaccine candidate developed by China-based biopharmaceutical products provider Sinovac Biotech Ltd's (NASDAQ: SVA) Sinovac Life business was approved by the National Medical Products Administration f...
Humanigen Inks Thermo Fisher Partnership to Expand Manufacturing for COVID-19 Therapeutic Candidate Lenzilumab
24 September 2020 - - US-based clinical stage biopharmaceutical company Humanigen, Inc., (NASDAQ: HGEN) has forged a strategic collaboration with US-based life science company Thermo Fisher Scientific (NYSE: TMO) to expand the manufacturing capa...